A proven management team.
The ARIAD management team is the right mix of talent, expertise and experience to lead our company as we build a leading integrated cancer company. In addition to people with proven scientific backgrounds, our team includes seasoned individuals who know how to build and run a business.
Executive Leadership Team
Harvey J. Berger, M.D.
Chairman and Chief Executive Officer
David L. Berstein, Esq.
Senior Vice President and Chief Intellectual Property Officer
Daniel M. Bollag, Ph.D.
Senior Vice President of Regulatory Affairs and Quality
Maria E. Cantor
Vice President, Corporate Communications and Investor Relations
Timothy P. Clackson, Ph.D.
Senior Vice President and Chief Scientific Officer
Virginia R. Dean
Vice President, Human Resources
Pierre F. Dodion, M.D.
Senior Vice President and Chief Medical Officer
Edward M. Fitzgerald
Senior Vice President, Chief Financial Officer and Treasurer
John D. Iuliucci, Ph.D.
Senior Vice President, Development
Raymond T. Keane, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Matthew E. Ros
Senior Vice President, Commercial Operations
Senior Management
Joseph Bratica
Vice President, Finance and Controller
David C. Dalgarno, Ph.D.
Vice President, Research Technologies
Frank G. Haluska, M.D., Ph.D.
Vice President, Clinical Affairs
Shirish Hirani, Ph.D.
Vice President, Program and Alliance Management
John W. Loewy, Ph.D.
Vice President, Biostatistics and Outcomes Research
Ross D. Pettit
Vice President, Clinical Operations
Victor M. Rivera, Ph.D.
Vice President, Preclinical and Translational Research
William C. Shakespeare, Ph.D.
Vice President, Drug Discovery
Kelly M. Schmitz
Vice President, Information Technology and Operations
Andreas Woppmann, Ph.D.
Vice President, Manufacturing Operations